DNA methylation and gene silencing in cancer
Nature Clinical Practice Oncology · 2005-12 · 2 (S1) · S4-S11
DOI: 10.1038/ncponc0354 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Oncology, 2005-12. Verfasst von Stephen B Baylin. Beteiligte Einrichtung: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. sbaylin@jhmi.edu. Hauptthemen laut MEDLINE: DNA Methylation, Gene Expression Regulation, Neoplastic, Gene Silencing. Die Arbeit wurde bisher 948-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. sbaylin@jhmi.edu
Zitieren
APA
Baylin, S. B. (2005). DNA methylation and gene silencing in cancer. Nature Clinical Practice Oncology, 2(S1), S4-S11. https://doi.org/10.1038/ncponc0354
Vancouver
Baylin SB. DNA methylation and gene silencing in cancer. Nature Clinical Practice Oncology. 2005;2(S1):S4-S11. doi:10.1038/ncponc0354
BibTeX
@article{Baylin2005,
author = {Baylin, Stephen B},
title = {DNA methylation and gene silencing in cancer},
journal = {Nature Clinical Practice Oncology},
year = {2005},
volume = {2},
number = {S1},
pages = {S4--S11},
doi = {10.1038/ncponc0354}
}
EUVIMED